ACE2 and atherosclerosis: Our data suggest that ACE2 is a key negative modulator of atherosclerosis-related kidney inflammation, oxidative stress and adverse renal injury, and targeting the ACE2/Ang-(1-7) signaling has potential therapeutic importance for preventing and treating atherosclerotic renal injury and kidney diseases.